Matthew Sharpe

Stock Analyst at Morgan Stanley

(2.55)
# 2,212
Out of 4,714 analysts
93
Total ratings
65.31%
Success rate
7.25%
Average return

Stocks Rated by Matthew Sharpe

Planet Labs PBC
Jun 12, 2023
Maintains: Equal-Weight
Price Target: $6$5.5
Current: $4.22
Upside: +30.33%
Parsons
May 16, 2023
Maintains: Underweight
Price Target: $39$41
Current: $92.30
Upside: -55.58%
Montrose Environmental Group
Mar 9, 2023
Maintains: Equal-Weight
Price Target: $47$43
Current: $19.20
Upside: +123.96%
Leidos Holdings
Feb 15, 2023
Maintains: Equal-Weight
Price Target: $111$105
Current: $147.15
Upside: -28.64%
CACI International
Feb 2, 2023
Maintains: Overweight
Price Target: $355$357
Current: $420.14
Upside: -15.03%
Booz Allen Hamilton Holding
Feb 2, 2023
Maintains: Overweight
Price Target: $118$116
Current: $131.93
Upside: -12.07%
Science Applications International
Jan 3, 2023
Downgrades: Equal-Weight
Price Target: $108$114
Current: $114.18
Upside: -0.16%
Primoris Services
Nov 16, 2022
Maintains: Overweight
Price Target: $30$28
Current: $79.60
Upside: -64.82%
Northrop Grumman
Jan 7, 2021
Maintains: Overweight
Price Target: $470$453
Current: $467.82
Upside: -3.17%
Lockheed Martin
Jan 7, 2021
Maintains: Overweight
Price Target: $509$480
Current: $481.82
Upside: -0.38%
Maintains: Overweight
Price Target: $248$235
Current: $209.75
Upside: +12.04%
Maintains: Underweight
Price Target: $146$151
Current: $263.37
Upside: -42.67%